Academia.eduAcademia.edu

Soft signs, attention, and startle in schizophrenia

1994, Biological Psychiatry

Abstract

the qualitative ratings were more sensitive to the group differences, explaining significantly more between group variance than the quantitative measures. The results suggest that human observers may be sensitive to important features of pathologic anatomy that are not fully revealed through quantitative methods.

NEUROLOGIC ABNORMALITIES IN SCHIZOPHRENIA

D. Ames t, T.C. Manschreck 2, & R.W. Buchanan 3

tWest Los Angeles VAMC and UCLA Department of Psychiatry, Los Angeles, CA 90073 2New Hampshire Hospital, Concord, NH 03301,~Maryland Psychiatric Research Center, Baltimore, MD 21228

Neurologic abnormalities in schizophrenic disorders may arise from four sources: (i) the disease itself; (2)its treatment; (3) a combination of ! and 2; and (4) factors associated with chrunicity, complications, and individual experience. Their clinical value has usually been associated with differential diagnosis. However, the clinical significance of neurologic abnormalities is likely to have other dimensions, including a role in early detection, relapse prediction, prognosis, response to treatment, and planning of long-term care and rehabilitation, as well as elucidation of pathogenesis and etiology. Research in neurologic features of schizophrenia has increased in recent years and several avenues have produced interesting findings. Among these are attempts to link features to the psychopathology of the disorder, to examine these features experimentally with laboratory measures, and to advance awareness of where these abnormalities originate in the brain. In addition to etiology of neurologic soft signs the presentations in this symposium will address methodologic issues of assessment of neurologic abnormalities. We report on our ongoing study of neurological soft signs (NSS) and their relationship to medication status and to negative symptoms in schizophrenia. Patients with schizophrenia, other psychiatric disorders, and controls were studied. An eight item instrument derived from the Neurological Evaluation Scale was used. A subgroup of patients were studied after at least two weeks on a fixed dose of haloperidol, then after at least two weeks medication free. Ratings of positive and negative symptoms and affective expression were done in both states. Interrater reliability and NSS prevalence with this shortened scale were comparable to other studies reported, with an excess of signs present in schizophrenics. Preliminary analysis of seven patients studied on and off medications revealed poorer performance in the medication-free patients, with the difference reaching statistical significance for the subgroup of complex motor acts. NSS are more prevalent in schizophrenic patients than controls, and appear to be affected by medication status. Data will be presented on an expanded group of patients, along with the results of clinical symptom and affective expression ratings. The possible relationship between negative symptoms and neurological signs will be discussed.